ProCE Banner Activity

Should All Adults 65 Years and Older With Early COVID-19 Receive Antivirals?

Clinical Thought
Here’s why I believe that antivirals should be administered to all adults aged 65 and older with early COVID-19 to reduce their risks of severe disease, hospitalization, and death.

Released: September 22, 2022

Expiration: September 21, 2023

Share

Faculty

Josep M. Llibre

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Josep M. Llibre, MD, PhD: consultant/advisor/speaker: Gilead Sciences, Janssen, ViiV Healthcare.